Skip to content
Oxandrolone
Oxandrin (oxandrolone) is a small molecule pharmaceutical. Oxandrolone was first approved as Oxandrin on 1982-01-01. It is used to treat emaciation and growth disorders in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Oxandrolone
Tradename
Company
Number
Date
Products
OXANDRINGemini LaboratoriesN-013718 DISCN1982-01-01
2 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
oxandrin2007-04-09
oxandroloneANDA2022-04-29
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
emaciation—D004614—
growth disorders—D006130—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
A: Alimentary tract and metabolism drugs
— A14: Anabolic agents for systemic use
— A14A: Anabolic steroids
— A14AA: Androstan derivatives
— A14AA08: Oxandrolone
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOXANDROLONE
INNoxandrolone
Description
Oxandrolone is a 3-oxo steroid, an oxa-steroid, a 17beta-hydroxy steroid and an anabolic androgenic steroid. It has a role as an androgen and an anabolic agent.
Classification
Small molecule
Drug classandrogens; steroids (not prednisolone derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C[C@]12COC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
Identifiers
PDB—
CAS-ID53-39-4
RxCUI7779
ChEMBL IDCHEMBL1200436
ChEBI ID7820
PubChem CID5878
DrugBankDB00621
UNII ID7H6TM3CT4L (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,133 documents
View more details
Safety
Black-box Warning
Black-box warning for: Oxandrin, Oxandrolone
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
2 adverse events reported
View more details